Short-chain fatty acids produced by synbiotic mixtures in skim milk differentially regulate proliferation and cytokine production in peripheral blood mononuclear cells

International Journal of Food Sciences and Nutrition

Volumn 66, Issue 7, 2015, Pages 755-765

  Asarat, M ^a   Apostolopoulos, V ^a   Vasiljevic, T ^a   Donkor, O ^a  

^a VICTORIA UNIVERSITY   (Australia)

Author keywords

Cytokines; Fermentation; Peripheral blood mononuclear cells; Probiotics; Short chain fatty acids

Indexed keywords

BETA GLUCAN; CYTOKINE; INULIN; LIPOPOLYSACCHARIDE; PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT; VOLATILE FATTY ACID;

ANIMAL; BIFIDOBACTERIUM; BIOSYNTHESIS; CELL PROLIFERATION; DRUG EFFECTS; FERMENTATION; HUMAN; INFLAMMATION; LACTOBACILLUS RHAMNOSUS; MAIZE; METABOLISM; MILK; MONONUCLEAR CELL;

ANIMALS; BETA-GLUCANS; BIFIDOBACTERIUM; CELL PROLIFERATION; CYTOKINES; FATTY ACIDS, VOLATILE; FERMENTATION; HUMANS; INFLAMMATION; INULIN; LACTOBACILLUS RHAMNOSUS; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MILK; PREBIOTICS; PROBIOTICS; SYNBIOTICS; ZEA MAYS;

EID: 84949978479     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.3109/09637486.2015.1088935     Document Type: Article

References (76)

1. Alles MS, Hautvast JG, Nagengast FM, Hartemink R, Van Laere KM, Jansen JB. 1996. Fate of fructo-oligosaccharides in the human intestine. Br J Nutr 76:211-221.
2. Amin M, Jorfi M, Khosravi A, Samarbafzadeh A, Sheikh AF. 2009. Isolation and identification of Lactobacillus casei and Lactobacillus plantarum from plants by PCR and detection of their antibacterial activity. J Biol Sci 9:810-814.
3. Anttila H, Sontag-Strohm T, Salovaara H. 2004. Viscosity of beta-glucan in oat products. Agric Food Sci 13:80-87.
4. Axelsson, L. 2004. Lactic acid bacteria: classification and physiology. Lactic Acid Bacteria Microbiol Funct Aspects 1-66.
5. Bailon E, Cueto-Sola M, Utrilla P, Rodriguez-Cabezas ME, Garrido-Mesa N, Zarzuelo A, Xaus J, et al 2010. Butyrate in vitro immunemodulatory effects might be mediated through a proliferation-related induction of apoptosis. Immunobiology 215: 863-873.
6. Bijjiga E, Martino AT. 2013. Interleukin 10 (IL-10) regulatory cytokine and its clinical consequences. J Clin Cell Immunol 1:2. Casterline J, Oles CJ, Ku Y. 1997. In vitro fermentation of various food fiber fractions. J Agric Food Chem 45: 2463-2467.
7. Cavaglieri CR, Nishiyama A, Fernandes LC, Curi R, Miles EA, Calder PC. 2003. Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes. Life Sci 73:1683-1690.
8. Chapoval S, Dasgupta P, Dorsey NJ, Keegan AD. 2010. Regulation of the T helper cell type 2 (Th2)/T regulatory cell (Treg) balance by IL-4 and STAT6. J Leukocyte Biol 87:1011-1018.
9. Chen J, Bruns AH, Donnelly HK, Wunderink RG. 2010. Comparative in vitro stimulation with lipopolysaccharide to study TNFalpha gene expression in fresh whole blood, fresh and frozen peripheral blood mononuclear cells. J Immunol Methods 357: 33-37.
10. Cox MA, Jackson J, Stanton M, Rojas-Triana A, Bober L, Laverty M, Yang X, et al 2009. Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E(2) and cytokines. World J Gastroenterol 15:5549-5557.
11. Cummings JH, Macfarlane GT. 2002. Gastrointestinal effects of prebiotics. Br J Nutr 87:S145-S151.
12. Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT. 1987. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28:1221-1227.
13. De Baere S, Eeckhaut V, Steppe M, De Maesschalck C, De Backer P, Van Immerseel F, Croubels S. 2013. Development of a HPLC-UV method for the quantitative determination of four short-chain fatty acids and lactic acid produced by intestinal bacteria during in vitro fermentation. J Pharm Biomed Anal 80:107-115.
14. Desai AR, Powell IB, Shah NP. 2004. Survival and activity of probiotic lactobacilli in skim milk containing prebiotics. J Food Sci 69: FMS57-FMS60.
15. Dinarello CA. 1998. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol 16:457-499.
16. Donkor ON, Henriksson A, Singh TK, Vasiljevic T, Shah NP. 2007a. ACEinhibitory activity of probiotic yoghurt. Int Dairy J 17: 1321-1331.
17. Donkor ON, Nilmini SLI, Stolic P, Vasiljevic T, Shah NP. 2007b. Survival and activity of selected probiotic organisms in set-type yoghurt during cold storage. Int Dairy J 17: 657-665.
18. Donkor ON, Ravikumar M, Proudfoot O, Day SL, Apostolopoulos V, Paukovics G, Vasiljevic T, et al 2012. Cytokine profile and induction of T helper type 17 and regulatory T cells by human peripheral mononuclear cells after microbial exposure. Clin Exp Immunol 167: 282-295.
19. Elamin EE, Masclee AA, Dekker J, Pieters HJ, Jonkers DM. 2013. Shortchain fatty acids activate amp-activated protein kinase and ameliorate ethanol-induced intestinal barrier dysfunction in Caco-2 cell monolayers. J Nutr.
20. Farooq U, Mohsin M, Liu X, Zhang H. 2013. Enhancement of short chain fatty acid production from millet fibres by pure cultures of probiotic fermentation. Trop J Pharm Res 12:189-194.
21. Fusunyan RD, Quinn JJ, Ohno Y, Macdermott RP, Sanderson IR. 1998. Butyrate enhances interleukin (IL)-8 secretion by intestinal epithelial cells in response to IL-1beta and lipopolysaccharide. Pediatr Res 43: 84-90.
22. Gibson GR, Beatty ER, Wang X, Cummings JH. 1995. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 108:975-982.
23. Gibson GR, Wang X. 1994. Enrichment of bifidobacteria from human gut contents by oligofructose using continuous culture. FEMS Microbiol Lett 118:121-127.
24. Guerrant GO, Lambert MA, Moss CW. 1982. Analysis of short-chain acids from anaerobic bacteria by high-performance liquid chromatography. J Clin Microbiol 16: 355-360.
25. Harris PJ, Smith BG. 2006. Plant cell walls and cell-wall polysaccharides: structures, properties and uses in food products. Int J Food Sci Technol 41:129-143.
26. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'garra A, Murphy KM. 1993. Development of TH1 CD4+T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-549.
27. Hughes SA, Shewry PR, Gibson GR, Mccleary BV, Rastall RA. 2008. In vitro fermentation of oat and barley derived beta-glucans by human faecal microbiota. FEMS Microbiol Ecol 64:482-493.
28. Jansky L, Reymanova P, Kopecky J. 2003. Dynamics of cytokine production in human peripheral blood mononuclear cells stimulated by LPS or infected by Borrelia. Physiol Res 52:593-598.
29. Kobori A, Bamba S, Imaeda H, Ban H, Tsujikawa T, Saito Y, Fujiyama Y, Andoh A. 2010. Butyrate stimulates IL-32alpha expression in human intestinal epithelial cell lines. World J Gastroenterol 16: 2355-2361.
30. Kruse HP, Kleessen B, Blaut M. 1999. Effects of inulin on faecal bifidobacteria in human subjects. Br J Nutr 82: 375-382.
31. Lambo AM, Öste R, Nyman MEGL. 2005. Dietary fibre in fermented oat and barley β-glucan rich concentrates. Food Chem 89:283-293.
32. Larkin Iii, J. 2013. Cytokine biology-cytokines at the interface of health and disease. J Clin Cell Immunol 4:e112.
33. Liu T, Li J, Liu Y, Xiao N, Suo H, Xie K, Yang C, Wu C. 2012. Shortchain fatty acids suppress lipopolysaccharide-induced production of nitric oxide and proinflammatory cytokines through inhibition of NF-kappaB pathway in RAW264.7 cells. Inflammation 35: 1676-1684.
34. Makras L, Falony G, Van Der Meulen R, De Vuyst L. 2006. Production of organic acids from fermentation of mannitol, fructooligosaccharides and inulin by a cholesterol removing Lactobacillus acidophilus strain. To editor. J Appl Microbiol 100:1388-1389.
35. Makras L, Van Acker G, De Vuyst L. 2005. Lactobacillus paracasei subsp. paracasei 8700:2 degrades inulin-type fructans exhibiting different degrees of polymerization. Appl Environ Microbiol 71: 6531-6537.
36. Mattern T, Flad HD, Brade L, Rietschel ET, Ulmer AJ. 1998. Stimulation of human T lymphocytes by LPS is MHC unrestricted, but strongly dependent on B7 interactions. J Immunol 160:3412-3418.
37. Mei GY, Carey CM, Tosh S, Kostrzynska M. 2011. Utilization of different types of dietary fibres by potential probiotics. Can J Microbiol 57:857-865.
38. Meijer K, De Vos P, Priebe MG. 2010. Butyrate and other short-chain fatty acids as modulators of immunity: what relevance for health? Curr Opin Clin Nutr Metab Care 13:715-721.
39. Menzel T, Luhrs H, Zirlik S, Schauber J, Kudlich T, Gerke T, Gostner A, et al 2004. Butyrate inhibits leukocyte adhesion to endothelial cells via modulation of VCAM-1. Inflamm Bowel Dis 10:122-128.
40. Mirmonsef P, Zariffard MR, Gilbert D, Makinde H, Landay AL, Spear GT. 2012. Short-chain fatty acids induce pro-inflammatory cytokine production alone and in combination with toll-like receptor ligands. Am J Reprod Immunol 67: 391-400.
41. Moore KW, De Waal Malefyt R, Coffman RL, O'garra A. 2001. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19: 683-765.
42. Moreira-Tabaka H, Peluso J, Vonesch JL, Hentsch D, Kessler P, Reimund JM, Dumont S, Muller CD. 2012. Unlike for human monocytes after LPS activation, release of TNF-a by THP-1 cells is produced by a TACE catalytically different from constitutive TACE. PLoS One 7: e34184.
43. Nancey S, Bienvenu J, Coffin B, Andre F, Descos L, Flourie B. 2002. Butyrate strongly inhibits in vitro stimulated release of cytokines in blood. Digest Dis Sci 47:921-928.
44. National Health and Medical Research Council, Australian Research Council, Australian Vice-Chancellors' Committee 2007. National Statement on Ethical Conduct in Human Research - Updated March 2014. Canberra: National Health and Medical Research Council.
45. Ngkelo A, Meja K, Yeadon M, Adcock I, Kirkham P. 2012. LPS induced inflammatory responses in human peripheral blood mononuclear cells is mediated through NOX4 and Gialpha dependent PI-3kinase signalling. J Inflamm 9:1.
46. Ongol M. 2012. Lactic acid bacteria in health and disease. Rwanda J Health Sci 1:39-50.
47. Palmer C, Diehn M, Alizadeh A, Brown P. 2006. Cell-type specific gene expression profiles of leukocytes in human peripheral blood. BMC Genom 7:115.
48. Patz J, Jacobsohn WZ, Gottschalk-Sabag S, Zeides S, Braverman DZ. 1996. Treatment of refractory distal ulcerative colitis with short chain fatty acid enemas. Am J Gastroenterol 91:731-734.
49. Pessione E. 2012. Lactic acid bacteria contribution to gut microbiota complexity: lights and shadows. Front Cell Infect Microbiol 2: 86-22.
50. Pokusaeva K, Fitzgerald GF, Van Sinderen D. 2011. Carbohydrate metabolism in Bifidobacteria. Genes Nutr 6:285-306.
51. Queenan K, Stewart M, Smith K, Thomas W, Fulcher RG, Slavin J. 2007. Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutr J 6:6.
52. Roberfroid MB, Van Loo JAE, Gibson GR. 1998. The bifidogenic nature of chicory inulin and its hydrolysis products. J Nutr 128:11-19.
53. Roque T, Boncoeur E, Saint-Criq V, Bonvin E, Clement A, Tabary O, Jacquot J. 2008. Proinflammatory effect of sodium 4-phenylbutyrate in DF508-cystic fibrosis transmembrane conductance regulator lung epithelial cells: involvement of extracellular signal-regulated protein kinase 1/2 and c-Jun-NH2-terminal kinase signaling. J Pharmacol Exp Ther 326:949-956.
54. Rossi M, Corradini C, Amaretti A, Nicolini M, Pompei A, Zanoni S, Matteuzzi D. 2005. Fermentation of fructooligosaccharides and inulin by Bifidobacteria: a comparative study of pure and fecal cultures. Appl Environ Microbiol 71:6150-6158.
55. Roy CC, Kien CL, Bouthillier L, Levy E. 2006. Short-chain fatty acids: ready for prime time? Nutr Clin Pract 21:351-366.
56. Rycroft CE, Jones MR, Gibson GR, Rastall RA. 2001. A comparative in vitro evaluation of the fermentation properties of prebiotic oligosaccharides. J Appl Microbiol 91:878-887.
57. Saemann MD, Bohmig GA, Osterreicher CH, Burtscher H, Parolini O, Diakos C, Stockl J, et al. 2000. Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and upregulation of IL-10 production. FASEB J 14:2380-2382.
58. Sanjabi S, Zenewicz LA, Kamanaka M, Flavell RA. 2009. Antiinflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity. Curr Opin Pharmacol 9: 447-453.
59. SAS Institute Inc. 2008. SAS/STAT® 9.2 User's Guide. Cary (NC): SAS Institute Inc.
60. Segain JP, Raingeard De La Bletiere D, Bourreille A, Leray V, Gervois N, Rosales C, Ferrier L, et al. 2000. Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut 47:397-403.
61. Shin HS, Lee JH, Pestka JJ, Ustunol Z. 2000. Growth and viability of commercial Bifidobacterium spp. in skim milk containing oligosaccharides and inulin. J Food Sci 65:884-887.
62. Sokol CL, Barton GM, Farr AG, Medzhitov R. 2008. A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat Immunol 9:310-318.
63. Tedelind S, Westberg F, Kjerrulf M, Vidal A. 2007. Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J Gastroenterol 13:2826-2832.
64. Topping DL, Clifton PM. 2001. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 81:1031-1064.
65. Trinchieri G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigenspecific adaptive immunity. Annu Rev Immunol 13:251-276.
66. Ulmer AJ, Flad HD, Rietschel T, Mattern T. 2000. Induction of proliferation and cytokine production in human T lymphocytes by lipopolysaccharide (LPS). Toxicology 152:37-45.
67. Vasiljevic T, Kealy T, Mishra VK. 2007. Effects of beta-glucan addition to a probiotic containing yogurt. J Food Sci 72:C405-C411.
68. Vernia P, Marcheggiano A, Caprilli R, Frieri G, Corrao G, Valpiani D, Di Paolo MC, et al. 1995. Short-chain fatty acid topical treatment in distal ulcerative colitis. Aliment Pharmacol Ther 9:309-313.
69. Vinolo MA, Rodrigues HG, Hatanaka E, Hebeda CB, Farsky SH, Curi R. 2009. Short-chain fatty acids stimulate the migration of neutrophils to inflammatory sites. Clin Sci London 117:331-338.
70. Vinolo MA, Rodrigues HG, Nachbar RT, Curi R. 2011. Regulation of inflammation by short chain fatty acids. Nutrients 3: 858-876.
71. Vrese M, Schrezenmeir J. 2008. Probiotics, prebiotics, and synbiotics. In: Stahl U, Donalies UB, Nevoigt E, editors. Food Biotechnology. Vol. 111. Berlin, Heidelberg: Springer. p 1-66.
72. Weber TE, Kerr BJ. 2006. Butyrate differentially regulates cytokines and proliferation in porcine peripheral blood mononuclear cells. Vet Immunol Immunopathol 113:139-147.
73. Wong JM, De Souza R, Kendall CW, Emam A, Jenkins DJ. 2006. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 40:235-243.
74. Yuan H, Liddle FJ, Mahajan S, Frank DA. 2004. IL-6-induced survival of colorectal carcinoma cells is inhibited by butyrate through downregulation of the IL-6 receptor. Carcinogenesis 25:2247-2255.
75. Zalán Z, Hudáč;ek J, Š; tě;tina J, Chumchalová J, Halász A. 2010. Production of organic acids by Lactobacillus strains in three different media. Eur Food Res Technol 230:395-404.
76. Zhao J, Cheung PC. 2011. Fermentation of β-glucans derived from different sources by bifidobacteria: evaluation of their bifidogenic effect. J Agric Food Chem 59:5986-5992.